Evidence-Based Oncology

Editorial Board Members

Evidence-Based Oncology

Joseph Alvarnas, MD
Vice President of Government Affairs, City of Hope
Chief Clinical Advisor, AccessHope
Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation
City of Hope
Duarte, CA
Associate Editor
Kashyap Patel, MD
Carolina Blood and Cancer Care Associates
Rock Hill, SC
Members of the Board

Michael E. Chernew, PhD
Leonard D. Schaeffer Professor of Health Care Policy
Department of Health Care Policy
Harvard Medical School
Boston, MA

Jonas de Souza, MD, MBA
Vice President, Strategy
HCA Healthcare
Nashville, TN

Jeffrey D. Dunn, PharmD, MBA
Chief Clinical Officer
Cooperative Benefits Group (CBG)
Draper, UT

Bruce A. Feinberg, DO
Vice President and Chief Medical Officer
Cardinal Health Specialty Solutions
Atlanta, GA

A. Mark Fendrick, MD
Professor of Medicine and Health Management and Policy
Schools of Medicine & Public Health
University of Michigan
Ann Arbor, MI

John L. Fox, MD, MHA
Senior Medical Director for the Americas, Illumina
Chief Boundary Spanner, Foxworthy Healthcare Consulting, LLC
Grand Rapids, MI
Bo Gamble
Director of Strategic Practice Initiatives
Community Oncology Alliance
Washington, DC
Lucio Gordan, MD
President and Managing Physician
Florida Cancer Specialists
Gainesville, FL
Michael Kolodziej, MD
Vice President and Chief Innovation Officer
ADVI Health, LLC
Washington, DC

Ellen Matloff, MS, CGC 
President and CEO
My Gene Counsel
North Haven, CT 
Kathy Oubre
Pontchartrain Cancer Center
Covington, LA

Debra Patt, MD, MPH, MBA
Executive Vice President
Texas Oncology
Austin, TX

Andrew L. Pecora, MD, FACP, CPE
Outcomes Matter Innovations, LLC
Hackensack, NJ

Stephen M. Schleicher, MD, MBA
Chief Medical Officer
Tennessee Oncology
Lebanon, TN

Lalan S. Wilfong, MD
Vice President, Payer Relations and Practice Transformation
The US Oncology Network
Dallas, TX
© 2023 MJH Life Sciences
All rights reserved.